To evaluate the clinical efficacy of Zhenjingdingzhi decoction in treating insomnia with Qi-deficiency of heart and gallbladder.
INTRODUCTION
Studies by the World Health Organization have shown that almost 30% people in the world suffer from insomnia. 1 Insomnia is recognized as one of the global public health issues which are not fully appreciated or well solved. 2 According to epidemiological studies, the incidence rate of insomnia in China is 10% to 20%. 3 In view of these facts, the late Professor Jianhua Hu, Shanghai famous specialist of Traditional Chinese Medicine (TCM), extracted Zhenjingdingzhi decoction to treat insomnia on basis of TCM theory, with reference to non-prescription medicine and literature, after decades of clinical trial and error. Zhenjingdingzhi decoction is modified from Ganmaidazao decoction, added Tiannanxing (Rhizoma Arisaematis Erubescentis), Shichangpu (Rhizoma Acori Tatarinowii), Zhenzhumu (Concha Margaritifera Usta), Yuanzhi (Radix Palygalae) and Danshen (Radix Salviae Miltiorrhizae). It has the effects of melting Phlegm, regulating Qi, supplementing Qi and nourishing heart to calm mind. In order to further verify the clinical efficacy of this decoction on insomnia, we observed and analyzed the therapeutic effect by comparing with Suanzaoren decoction 4, 5 which is widely approved at home and abroadto provide the basis for the clinical treatment of insomnia and further explore the new direction of treating sleep disorders in TCM.
MATERIALS AND METHODS

Diagnostic standards
Diagnostic standards of insomnia in Western Medicine are stipulated by Chinese Classification of Mental Disorders Third Edition (CCMD-3) (F51.0). 6 In reference to Guidelines for Diagnosis and Treatment of Common Internal Diseases in Chinese Medicine Symptoms of Chinese Medicine, 7 standard for diagnosing in TCM defines main syndromes as difficulty in falling asleep, or waking up easily, or waking up frequently during the night with difficulty of returning to sleep, or keeping sleepless all night, and symptoms persisting for more than 4 weeks. Also we adopted accompanying symptoms as follows: dreaminess, vexation, dizziness and headaches, palpitation and amnesia, fatigue and lassitude, without other organic disease or inducement that violate sleep. The main syndromes of Qi-deficiency of heart and gallbladder type referring to Clinic Terminology of Traditional Chinese Medical Diagnosis and Treatment-Syndromes GB/T16751. 8 includes palpitation and timidity, inability to fall asleep, festless sleep, and the secondary syndromes includes be-ing susceptible to fright, shortness of breath and lassitude, lack of strength and spontaneous perspiration. And main feature of tongue and pulse diagnosis: whitish tongue and white fur, stringy-thready pulse.
Inclusion standards
Patients were included if they: (a) conformed to the above-mentioned diagnostic standards; (b) were 18-65 years old; (c) suffer from insomnia over 4 weeks. All patients volunteered for this trial and provided written informed consent. The study was approved by Medical Ethics Committee, Shanghai Longhua Hospital Affiliated to Shanghai University of TCM.
Exclusion standards
Patients were excluded if they: (a) did not conform the diagnostic standards of insomnia or Qi-deficiency of heart and gallbladder; (b) were < 18 years old or > 65 years old; (c) were pregnant or lactating; (d) had diabetes, psychiatric disorder or serious suicidal tendency.
Eliminating cases and standards of dropout
Patients were eliminated if they: (a) stopped the treatment halfway due to adverse reactions or non-efficacy reasons; (b) added other drugs; (c) provided incomplete data that couldn't be counted; (d) did not complete the therapy as planned; (e) did not conform to inclusion standards but were included by mistake. Patients were considered dropouts of the study if they had poor compliance, serious adverse reactions, complications or special physiological changes that made them inappropriate to continue the trial during the therapy. When data were statistically analyzed, adverse reactions should be recorded in the statistics of adverse reaction and patients who had completed 1/2 of the therapy should be evaluated the efficacy.
Randomization, double-blind method
From October 2012 to September 2013, a cohort of 100 insomnia patients who visited Neurology Department of Longhua Hospital Affiliated to Shanghai University of TCM was recruited and divided randomly into two groups of 50 by their visiting sequence. The medicine of the two groups was uniformly decocted, packaged by the Department of Pharmaceutical Preparation of Longhua Hospital Affiliated to Shanghai University of TCM, Shanghai, China. According to a random number table, each study decoction was randomly numbered and indicated on the package. The researchers issued the study decoction on the basis of the subjects visiting sequence which was consistent with that on the decoction package. At the end of the trial, we entered the observation data into the established database. Primary unblinding was executed when the data was locked by the statistics professional. And A group and B group were established. Secondary unblinding was executed when the statistics was completed, and the treatment group and the control group were definite.
Therapy
Before the trial was started, all the patients were included after one-week washout period. The treatment group was given Zhenjingdingzhi decoction, which consisted of Tiannanxing (Rhizoma Arisaematis Erubescentis), Shichangpu (Rhizoma Acori Tatarinowii), Zhenzhumu (Concha Margaritifera Usta), Yuanzhi (Radix Palygalae), Danshen (Radix Salviae Miltiorrhizae), Fuxiaomai (Fructus Tritici Levis), Dazao (Fructus Jujubae), and Gancao (Radix Glycyrrhizae). The control group was treated with Suanzaoren decoction which consisted of Fuling (Poria), Zhimu (Rhizoma Anemarrhenae), Chuanxiong (Rhizoma Chuanxiong), Suanzaoren (Semen Ziziphi Spinosae) and Prepared Gancao (Radix Glycyrrhizae). The above herbs were decocted for 30 min and concentrated to 150 mL juice twice. The two juices were mixed together. The dosage of herbal decoction was 300 mL every day with 150 mL taken orally in the morning and evening for 8 weeks. All the medicine of the two groups was uniformly decocted, packaged by the Department of Pharmaceutical Preparation of Longhua Hospital Affiliated to Shanghai University of TCM. Rules of drug combinations: patients were not allowed to take other hypnotic, antipsychotics, antidepressant, hypnotic drugs and any drug that causes insomnia.
Efficacy evaluation
Clinical indexes: we recorded Spiegel scale, Pittsburgh sleep quality index (PSQI) and TCM syndrome score at weeks 0, 4 and 8. And we assessed the clinical efficacy based on reduction rate. Clinical recovery was defined as reduction rate ≥ 75%. If the reduction rate was between 50% and 74% , then the clinical efficacy was marked effective. If the reduction rate was between 25% and 49%, then it was effective. Recovery was invalid if the reduction rate was less than 25% . Reduction rate = (score before treatmentscore after treatment) / score before treatment × 100%.
Safety evaluation
Blood routine, urine routine, hepatic and renal function including aspartate transaminase (AST), alanine aminotransferase (ALT), creatinine (Cr), blood urea ni-trogen (BUN), and electrocardiogram were detected before and after treatment. Adverse events were observed and recorded during the treatment.
Statistical methods
All the data were analyzed with SPSS 18.0 software packet (Chicago, IL, USA). Measurement data was expressed with mean ± standard deviation ( x ± s). Group t-test was used when measurement data was normal distribution and homogeneity of variance, otherwise t-test was used. χ 2 test was used for enumeration data, and rank-sum test was used for ranked data. A P value < 0.05 was considered to be statistically significant.
RESULTS
Comparison of the general statistics before treatment
A hundred patients were recruited and divided randomly into the treatment and the control group with 50 patients in each. During the trial, 3 of the 100 patients were lost. Of the 3 lost, 1 discontinued for poor compliance and 2 for side effects like headache and vertigo. They were all from the control group. Finally, 97 patients completed the trial, 50 in the treatment group and 47 in the control group. The flow diagram of the trial is shown in Figure 1 . All the data from these 3 participants were excluded from the statistical analysis. The two groups had no significant differences in age, gender, duration of symptoms, PSQI scores or Spiegel scores before treatment (all P > 0.05) as shown in Table 1 . The two groups were comparable.
Comparison of Spiegel scores before and after treatment
The total effective rate was 46% in the treatment group and 27.7% in the control group after 4 weeks of treatment, and 80% and 53.2% after 8 weeks of treatment, respectively. The statistical test showed that the differences in curative effect were both significant (P < 0.05). The curative effect in the treatment group was superior to that in the control group. 
Comparison of PSQI scores before and after treatment
After 4 weeks of treatment, the total effective rate was 64% in the treatment group and 42.6% in the control group. There was no statistical difference (P > 0.05) between the two groups. After 8 weeks of treatment, the total effective rate was 84% in the treatment group and 59.6% in the control group. The curative effect of the treatment group was obviously better than that of the control group (P < 0.01). In improving sleep quality and sleep duration, the curative effect of the treatment group was better than that of the control group (P < 0.05). The mean ranks of the treatment group and the control group were 55.14 and 54.14, 42.47 and 42.37, respectively ( Table 3, 4) .
Comparison of TCM syndrome scores before and after treatment
The total effective rate was 44% in the treatment group and 34% in the control group after 4 weeks of treatment, and 80% and 53.2% after 8 weeks of treatment, respectively. After 4 weeks of treatment, there was no obvious difference (P > 0.05) between the two groups. However, the total effective rate in the treatment group was much higher than that in the control group (P < 0.01). TCM syndrome, especially insomnia and palpitation, was improved better in the treatment group after 8 weeks as compared to that in the control group (P < 0.05). The mean ranks of the treatment group and the control group were 41.89 and 28.50, 55.39 and 36.98, respectively ( Table 5, 6) .
Safety
Before and after treatment in the two groups, blood routine, urine routine, electrocardiogram examination, hepatic and renal function revealed no abnormal changes in any patients in either group. This indicated that Zhenjingdingzhi decoction was safe. Among 100 pa- Table 2 Comparison of curative effects in Spiegel scores between the two groups after 4 and 8 weeks of treatment Notes: the treatment group was given Zhenjingdingzhi decoction (150 mL, each time, twice a day) and the control group was treated with Suanzaoren decoction (150 mL, each time, twice a day). a P < 0.05 as compared with the data of control group. tients which were included in the trial, 6 patients had adverse reactions (1 in treatment group and 5 in control group). In the control group, 2 cases withdrew from the study due to mouth and tongue sore, diarrhea and pharyngodynia. And 4 cases had gastrointestinal adverse reactions such as flatulence and nausea. All the adverse reactions were mild and disappeared or alleviated 1 week after withdrawal of drug. Notes: the treatment group was given Zhenjingdingzhi decoction (150 mL, each time, twice a day) and the control group was treated with Suanzaoren decoction (150 mL, each time, twice a day). a P < 0.01 compared with the data of control group. PSQI: Pittsburgh sleep quality index. Table 3 Comparison of curative effects in PSQI scores between the two groups after 4 weeks and 8 weeks of treatment Table 4 Comparison of curative effects in each item of PSQI after 8 weeks of treatment Notes: the treatment group was given Zhenjingdingzhi decoction (150 mL, each time, twice a day) and the control group was treated with Suanzaoren decoction (150 mL, each time, twice a day). a P < 0.05 as compared with the data of control group. PSQI: Pittsburgh sleep quality index. Table 5 Comparison of curative effects in TCM syndrome between the two groups after 4 and 8 weeks of treatment Notes: the treatment group was given Zhenjingdingzhi decoction (150 mL, each time, twice a day) and the control group was treated with Suanzaoren decoction (150 mL, each time, twice a day). a P < 0.01 as compared with the data of control group. TCM: Traditonal Chinese Medicine.
DISCUSSION
With social and economic development, more people suffer from insomnia. 9 Many western hypnotics have been developed in recent years, such as benzodiazepine derivatives, non-benzodiazepine hypnotics, and z-drugs like zolpidem, zopiclone, eszopiclone and zaleplon. [10] [11] [12] Each drug acts on neurotransmitters or receptors to produce sedative and hypnotic effects. However, the medications have short durations of action, and some have a risk of tolerance or abuse. 13 They may also cause impairments in memory and cognitive function, especially benzodiazepine derivatives. 14 Thus, developing effective medicines without side effects to treat insomnia is particularly urgent. Insomnia, is called Bu Mei in TCM, and early documented as mu bu ming (unclosed eyes), wo Bu An (unease sleep), bu De Wo (unable to lie down) in Huang Di Nei Jing. 15 Tai Ping Sheng Hui Fang 16 of Song Dynasty points out that insomnia due to insufficiency of the gallbladder-Qi has close relation with heart. And injury of heart-Qi, hidden pathogen in gallbladder and deficiency-cold of liver and gallbladder lead to difficulty in lying down. It also maintains the relationship between heart and gallbladder and began to emphasize the combination therapy for heart and gallbladder. It might be said that the book developed the new category of treatment variation for insomnia due to insufficiency of the gallbladder-Qi. 17 Yi Zong Jin Jian says that insufficiency of gallbladder-Qi causing timidity is essential to difficulty in lying down due to fear. 18 As stated in the Shen Shi Zun Sheng Shu·Bu Mei, 19 timidity of heart and gallbladder and susceptibility to fright cause nightmares, dysphoria and hypersomnia. It shows that debility of heart and gallbladder leads to being vulnerable to panic and restless sleep. And sometimes tension and anxiety because of the sudden shock make decision function of gallbladder damaged which means it is easy to feel uneasy and produces symptoms like insomnia, dreaminess and easily awakened, etc. 20 Zhu et al 21 collected 120 patients with insomnia and the syndrome differentiation shows that types of Qi-deficiency of heart and gallbladder, hyperactivity of fire due to Yin-deficiency and deficiency of both heart and spleen accounted for 60% of the subjects. Chen et al 22 adopted a syndrome differentiation of 75 insomnia patients and the result showed that over 30% of the patients were the Qi-deficiency of heart and gallbladder type. Thus it can be seen that insomnia is deficiency-excess complex, but deficiency syndrome is in the majority in clinic, especially the type of Qi-deficiency of heart and gallbladder. According to its pathogenic characteristics, nourishing heart and tranquilizing mind are the main ideas for syndrome differentiation and treatment. Suanzaoren decoction obtained from Jin Kui Yao Lue of Zhangzhongjing for the treatment of insomnia with deficiency syndromes 23 and its effectiveness had been verified by TCM doctors of past dynasties. 24 Gu Jin Ming Yi Fang Lun 25 Table 6 Comparison of curative effects in each item of TCM syndromes between the two groups after 8 weeks of treatment Notes: the treatment group was given Zhenjingdingzhi decoction (150 mL, each time, twice a day) and the control group was treated with Suanzaoren decoction (150 mL, each time, twice a day). a P < 0.05 as compared with the data of control group. TCM: Traditonal Chinese Medicine.
treating consumptive disease and blood-deficiency in liver. In Ben Cao Yi Du, 26 it is the best decoction for treating consumptive disease and insomnia with weakness and irritability. A large number of domestic and foreign clinical research and modern pharmacological experimental studies showed that Suanzaoren decoction had a better sleep improvement effect. [27] [28] [29] This study used Suanzaoren decoction as the control drug to evaluate the clinical efficacy of Zhenjingdingzhi decoction on treating insomnia. Zhenjingdingzhi decoction was extracted by the late Professor Jianhua Hu, Shanghai famous specialist of TCM, originating from the therapy theory of tranquilizing mind by nourishing the heart. It was based on the famous prescription Ganmaidazao decoction from Prescriptions of the Jin Kui Yao Lue·Fu Ren Za Bing 30 of Zhang Zhongjing, adding Danshen (Radix Salviae Miltiorrhizae), Shichangpu (Rhizoma Acori Tatarinowii), Yuanzhi (Radix Palygalae), etc. Danshen (Radix Salviae Miltiorrhizae) has the property of nourishing blood and tranquilizing mind. Gancao (Radix Glycyrrhizae), Fuxiaomai (Fructus Tritici Levis) and Dazao (Fructus Jujubae) have the function of alleviating pain and make a good effect on nourishing heart-Qi and tranquilizing mind. Shichangpu (Rhizoma Acori Tatarinowii), Yuanzhi (Radix Palygalae), and Tiannanxing (Rhizoma Arisaematis Erubescentis) can eliminate phlegm for resuscitation and relieve stasis. Zhenzhumu (Concha Margaritifera Usta) has the effect on checking and descending the upward rebellious Qi. Compatibility of all the medicine makes therapeutic effect on nourishing heart, tranquilizing mind, resuscitation and relieve stasis. This study indicates that Zhenjingdingzhi decoction is effective and safe for the treatment of insomnia with Qi-deficiency of heart and gallbladder, especially for improving sleep quality and sleep duration.
